479
Views
28
CrossRef citations to date
0
Altmetric
Articles

Air quality modeling for health risk assessment of ambient PM10, PM2.5 and SO2 in Iran

, , , , , , , & show all
Pages 1298-1310 | Received 04 May 2018, Accepted 07 Jun 2018, Published online: 02 Nov 2018

References

  • Al-Hemoud A, Al-Dousari A, Al-Shatti A, Al-Khayat A, Behbehani W, and Malak M. 2018. Health impact assessment associated with exposure to PM10 and dust storms in Kuwait. Atmos 9:6.
  • Asl BF, Leili M, Vaziri Y, Salahshour Arian S, Cristaldi A, Oliveri Conti G, and Ferrante M. 2018. Health impacts quantification of ambient air pollutants using AirQ model approach in Hamadan, Iran. Environ Res 161:114–21.
  • Atkinson RW, and Anderson HR. 1997. Daily time series for cardiovascular hospital admissions and previous day's air pollution in London, UK. Occup Environ Med 54:535–40.
  • Biggeri A, Bellini P, and Terracini B. 2001. Meta analysis of the Italian studies on short-term effects of air pollution. J Epidemio 4:25–27.
  • Boldo E, Linares C, Lumbreras J, Borge R, Narros A, García-Pérez J, Fernández-Navarro P, Pérez-Gómez B, Aragonés N, and Ramis R. 2011. Health impact assessment of a reduction in ambient PM2. 5 levels in Spain. Environment Int 37:342–48.
  • Burnett RT, Cakma KS, Brook JS, et al. 1997. The role of particulate size and chemistry in the association between summer time ambient air pollution and hospitalization for cardiorespiratory diseases. Environ Health Perspect 105:614–20.
  • Burret RT, and Doles RE. 1997. Association between ambient carbon monoxide levels and hospitalization for congestive heart failure in the elderly in 10 Canadian cities. Epidemiology 8:162–67.
  • Chen R, Pan G, Kan H, Tan J, Song W, and Wu Z. 2010. Ambient air pollution and daily mortality in Anshan, China: a time-stratified case-crossover analysis. Sci Total Environ 408:6086–91.
  • Daryanoosh M, Goudarzi G, Rashidi R, Keishams F, Hopke PK, Mohammadi MJ, Nourmoradi H, Sicard P, Takdastan A, and Vosoughi M. 2017. Risk of morbidity attributed to ambient PM10 in the western cities of Iran. Toxin Rev 1–6.
  • De Marco et al. 2018. Mortality and morbidity for cardiopulmonary diseases attributed to PM2.5 exposure in the metropolis of Rome, Italy, European. Journal of Internal Medicine. DOI: 10.1016/j.ejim.2018.07.027
  • Dobaradaran S, Geravandi S, Goudarzi G, Idani E, Salmanzadeh S, Soltani F, Yari AR, and Mohammadi MJ. 2016. Determination of cardiovascular and respiratory diseases caused by PM10 exposure in Bushehr, 2013. J Mazandaran Univ Med Sci 26:42–52.
  • Fattore E, Paiano V, Borgini A, Tittarelli A, Bertoldi M, Crosignani P, and Fanelli R. 2011. Human health risk in relation to air quality in two municipalities in an industrialized area of Northern Italy. Environ Res 111:1321–27.
  • Geravandi S, Sicard P, Khaniabadi YO, De Marco A, Ghomeishi A, Goudarzi G, Mahboubi M, Yari AG, Dobaradaran S, Hassani G, Mohammadi MJ, and Sadeghi S. 2017. A comparative study of hospital admissions for respiratory diseases during normal and dusty days in Iran. Environ Sci Pollut Res Int 24:18152–59.
  • Goudarzi G, Geravandi S, Idani E, Hosseini SA, Baneshi MM, Yari AR, Vosoughi M, Dobaradaran S, Shirali S, and Marzooni MB. 2016. An evaluation of hospital admission respiratory disease attributed to sulfur dioxide ambient concentration in Ahvaz from 2011 through 2013. Environ Sci Pollut Res Int 23:22001–07.
  • Gouveia N, deFreitas CU, Martins LC, et al. 2006. Respiratory and cardiovascular hospitalizations associated with air pollution in the city of Sao Paulo, Brazil. Cad. De. Saude Publica 22:2669–77.
  • Guo et al. 2010. Gaseous air pollution and emergency hospital visits for hypertension in Beijing, China: a time-stratified case-crossover study. Environmental Health 2010 9:57.
  • Javanmardi P, Pouran M, Majid F, Sahar G, Yusef Omidi K, Kambiz Ahmadi A, Adewale Matthew T, Pierre S, Gholamreza G, and Valipour A. 2018. Monitoring the impact of ambient ozone on human health using time series analysis and air quality model approaches', Fresenius Environ Bulletin 27:533–44.
  • Jeong SJ. 2013. The impact of air pollution on human health in Suwon City. Asian J Atmos Environ 7:227–33.
  • Khaefi M, Geravandi S, Hassani G, Yari AR, Soltani F, Dobaradaran S, Moogahi S, Mohammadi MJ, Mahboubi M, and Alavi N. 2017. Association of particulate matter impact on prevalence of chronic obstructive pulmonary disease in Ahvaz, southwest Iran during 2009–2013. Aerosol Air Qual Res 17:230–37.
  • Khaniabadi YO, Goudarzi G, Daryanoosh SM, Borgini A, Tittarelli A, and De Marco A. 2016. Exposure to PM10, NO2, and O3and impacts on human health. Environ Sci Pollut Res 24:2781–2789: DOI 10.1007/s11356-016-8038-6.
  • Khaniabadi et al. (2017) Hospital admissions in Iran for cardiovascular and respiratory diseases attributed to the Middle-Eastern Dust Storms. Environmental Science and Pollution Research 20:16860–16868.
  • Khaniabadi YO, Daryanoosh M, Pierre S, Afshin T, Philip KH, Shirin E, De Marco A, and Rashidi R. 2018. Chronic obstructive pulmonary diseases related to outdoor PM10, O3, SO2, and NO2 in a heavily polluted megacity of Iran. Environ Sci Pollution Res 25:1–9.
  • Khaniabadi YO, Daryanoosh SM, Amrane A, Polosa R, Hopke PK, Goudarzi G, Mohammadi MJ, Sicard P, and Armin H. 2017. Impact of middle eastern dust storms on human health. Atmos Poll Res 8:606–13.
  • Khaniabadi YO, Daryanoosh SM, Hopke PK, Ferrante M, De Marco A, Sicard P, Oliveri Conti G, Goudarzi G, Basiri H, and Mohammadi MJ. 2017. Acute myocardial infarction and COPD attributed to ambient SO2 in Iran. Environ Res 156:683–87.
  • Khaniabadi YO, Goudarzi G, Daryanoosh SM, Borgini A, Tittarelli A, and De Marco A. 2017. Exposure to PM10, NO2, and O3 and impacts on human health. Environ Sci Poll Res 24:2781–89.
  • Khaniabadi YO, Hopke PK, Goudarzi G, Daryanoosh SM, Jourvand M, and Basiri M. 2017. Cardiopulmonary mortality and COPD attributed to ambient ozone. Environ Res 152:336–41.
  • Khaniabadi,YO, Polosa R, Chuturkova RZ, Daryanoosh M, Goudarzi G, Borgini A, Tittarelli A, Basiri H, Armin H, and Nourmoradi H. 2017. Human health risk assessment due to ambient PM10 and SO2 by an air quality modeling technique. Process Safety Environ Protec 111:346–54.
  • Khaniabadi YO, Pierre S, Adewale MT, De Marco A, Shirin E, and Rashidi R. 2018. Modeling of particulate matter dispersion from a cement plant: upwind-downwind case study. J Envir Chem Eng 6:3104–3110.
  • Khaniabadi et al. 2018. Mortality and morbidity due to ambient air pollution in Iran. Clinical Epidemiology and Global Health. DOI: 10.1016/j.cegh.2018.06.006.
  • Laden F, Schwartz J, Speizer FE, and Dockery DW. 2006. Reduction in fine particulate air pollution and mortality: extended follow-up of the Harvard six cities study. Am J Res Crit Care Med 173:667–72.
  • Lippmann, M, Ito K, Nadas A, and Burnett RT. 2000. Association of particulate matter components with daily mortality and morbidity in urban populations. Res Rep Health Eff Inst 95:5–72.
  • Lu F, Xu D, Cheng Y, Dong S, Guo C, Jiang X, and Zheng X. 2015. Systematic review and meta-analysis of the adverse health effects of ambient PM2.5 and PM10 pollution in the Chinese population. Environ Res 136:196–204.
  • Martinelli N, Olivieri O, and Girelli D. 2013. Air particulate matter and cardiovascular disease: A narrative review. Eur J Int Med 24:295–302.
  • Merrifield A, Schindeler S, Jalaludin B, and Smith W. 2013. Health effects of the September 2009 dust storm in Sydney, Australia: did emergency department visits and hospital admissions increase? Envir Health 12:32.
  • Middleton N, Yiallouros P, Kleanthous S, Kolokotroni O, Schwartz J, Dockery DW, Demokritou P, and Koutrakis P. 2008. A 10-year time-series analysis of respiratory and cardiovascular morbidity in Nicosia, Cyprus: the effect of short-term changes in air pollution and dust storms. Environ Health 7:39.
  • Momtazan M, Geravandi S, Rastegarimehr B, Valipour A, Ranjbarzadeh A, Yari AR, Dobaradaran S, Bostan H, Farhadi M, and Darabi F. 2018. An investigation of particulate matter and relevant cardiovascular risks in Abadan and Khorramshahr in 2014–2016. Toxin Rev 25:1–8.
  • Nagpure AS, Gurjar BR, and Martel Jc. 2014. Human health risks in national capital territory of Delhi due to air pollution. Atmos Poll Res 5:371–80.
  • Omidi Y, Goudarzi G, Heidari AM, and Daryanoosh SM. 2016. Health impact assessment of short-term exposure to NO2 in Kermanshah, Iran using AirQ model. Environ Health Eng Manag J 3:91–97.
  • Orru H, Maasikmets M, Lai T, Tamm T, Kaasik M, Kimmel V, Orru K, Merisalu E, and Forsberg B. 2011. Health impacts of particulate matter in five major Estonian towns: main sources of exposure and local differences. Air Qual Atmos Health 4:247–58.
  • Park J, Lim N, Hong M, Kim Y, and Jin W. 2015. The influence of Asian dust, haze, mist, and fog on hospital visits for airway diseases. Tuberc Respir Dis (Seoul) 78:326–35.
  • Pope CA, Burnett RT, Thun MJ, Calle EE, Krewski D, and Thurston GD. 2002. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. J Am Med Ass 287:1132–41.
  • Sarigiannis DA, Kermenidou M, Nikolaki S, Zikopoulos D, and Karakitsios SP. 2015. Mortality and morbidity attributed to aerosol and gaseous emissions from biomass use for space heating. Aero Air Qual Res 15:2496–507
  • Shahsavani A, Naddafi K, Jafarzade Haghighifard N, Mesdaghinia A, Yunesian M, Nabizadeh R, Arahami M, Sowlat MH, Yarahmadi M, and Saki H. 2012. The evaluation of PM10, PM2.5, and PM1 concentrations during the Middle Eastern Dust (MED) events in Ahvaz, Iran, from april through September 2010. J Arid Environ 77:72–83.
  • Shakour, A, El-Shahat M, El-Taieb N, Hassanein M, and Mohamed A. 2011. Health impacts of particulate matter in greater Cairo, Egypt. J Am Sci 7:840–48.
  • Sicard P, Lesne O, Alexandre N, Mangin A, and Collomp R. 2011. Air quality trends and potential health effects–development of an aggregate risk index. Atmospheric Environ 45:1145–53.
  • Sicard P, Talbot C, Lesne O, Mangin A, Alexandre N, and Collomp R. 2012. The aggregate risk index: an intuitive tool providing the health risks of air pollution to health care community and public. Atmos Envir 46:11–16.
  • Sunyer Ballester F, Tertre AL, Atkinson R, Ayres JG, Forastiere F, and Forsberg B. 2003. The association of daily sulfur dioxide air pollution levels with hospital admissions for cardiovascular diseases in Europe (The Aphea-II study). Eur Heart J 24:752–60.
  • Tominz R, Mazzoleni B, and Daris F. 2005. Estimate of potential health benefits of the reduction of air pollution with PM10 in Trieste, Italy. Epidemiol. Prev 29:149–55.
  • Touloumi G 1997. Short-term effects of ambient oxidant exposure on mortality: a combined analysis within the APHEA project. Air pollution and health: a European approach. Am J Epidemiol 146:177–85.
  • Wong CM, Atkinson RW, Anderson HR, Hedley AJ, Ma S, Chau PYK, and Lam TH. 2002. A tale of two cities: effects of air pollution on hospital admissions in Hong Kong and London compared. Environ Health Persp 110:67–77.
  • Yari AR, Goudarzi G, Geravandi S, Dobaradaran S, Yousefi F, Idani E, Jamshidi F, Shirali S, Khishdost M, and Mohammadi MJ. 2016. Study of ground-level ozone and its health risk assessment in residents in Ahvaz City, Iran during 2013. Toxin Rev 35:201–06.
  • Zhou M, Liu Y, Wang L, Kuang X, Xu X, and Kan H. 2014. Particulate air pollution and mortality in a cohort of Chinese men. Environ Pollut 186:1–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.